| scholarly article | Q13442814 |
| P2093 | author name string | Andrea Petrucci | |
| Sandro Panese | |||
| Francesca Cattelan | |||
| Enzo Raise | |||
| Andrea Barelli | |||
| Erika Morelli | |||
| Francesca Cavinato | |||
| Franklyn Eseme | |||
| Pierluigi Brugnaro | |||
| P2860 | cites work | Lung cancer in HIV positive patients: the GICAT experience | Q95563732 |
| Characteristics and outcome of AIDS-related Hodgkin lymphoma before and after the introduction of highly active antiretroviral therapy | Q95801538 | ||
| Clonal integration of a polyomavirus in human Merkel cell carcinoma | Q24657675 | ||
| Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS | Q24685909 | ||
| 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults | Q28184343 | ||
| Survival in HIV-infected patients after a cancer diagnosis in the cART Era: results of an italian multicenter study | Q28538165 | ||
| HIV induces TRAIL sensitivity in hepatocytes | Q33413051 | ||
| Human immunodeficiency virus-associated primary lung cancer in the era of highly active antiretroviral therapy: a multi-institutional collaboration. | Q33742919 | ||
| HIV infection and the risk of cancers with and without a known infectious cause | Q33827510 | ||
| Decline in the AIDS and death rates in the EuroSIDA study: an observational study | Q33967061 | ||
| The epidemiology of acquired immunodeficiency syndrome malignancies | Q34009748 | ||
| Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study | Q34059657 | ||
| Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy | Q34093851 | ||
| Cancer as a Cause of Death among People with AIDS in the United States | Q34148135 | ||
| Hepatitis C virus infection in the human immunodeficiency virus infected patient | Q34168504 | ||
| Hodgkin's Disease in Patients with HIV Infection | Q34169941 | ||
| Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy | Q34332052 | ||
| Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy | Q34403321 | ||
| Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome | Q34510917 | ||
| Elevated incidence of lung cancer among HIV-infected individuals | Q34565809 | ||
| Trends in cancer risk among people with AIDS in the United States 1980-2002. | Q34569368 | ||
| Elevated risk of lung cancer among people with AIDS. | Q34573678 | ||
| Acute myeloid leukemia in patients infected with HIV-1. | Q34580249 | ||
| Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis | Q34580943 | ||
| HIV infection and lymphoma | Q34585452 | ||
| Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma | Q34597963 | ||
| A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals | Q34612071 | ||
| HIV- positive anal cancer: an update for the clinician | Q34640551 | ||
| Epstein-Barr virus-associated lymphoproliferative disorders. | Q34654750 | ||
| British HIV Association guidelines for HIV-associated malignancies 2014. | Q34659682 | ||
| Spectrum of AIDS-associated malignant disorders | Q34748862 | ||
| Characteristics of non-AIDS-defining malignancies in the HAART era: a clinico-epidemiological study | Q34774173 | ||
| Skin cancers after organ transplantation | Q35113533 | ||
| Risk assessment in human immunodeficiency virus-associated acute myeloid leukemia | Q45363060 | ||
| Anal carcinoma in human immunodeficiency virus-positive men: results of a prospective study from Germany | Q45378394 | ||
| Cancer risk in people infected with human immunodeficiency virus in the United States | Q45395561 | ||
| Acute myeloid leukaemia in human immunodeficiency virus-infected adults: epidemiology, treatment feasibility and outcome | Q45737809 | ||
| Changes in acquired immunodeficiency syndrome-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: incidence, presentation, treatment, and survival | Q46164918 | ||
| Chemotherapy consisting of doxorubicin, bleomycin, vinblastine, and dacarbazine with granulocyte-colony-stimulating factor in HIV-infected patients with newly diagnosed Hodgkin's disease: a prospective, multi-institutional AIDS clinical trials group | Q46312662 | ||
| Tobacco use and readiness to quit smoking in low-income HIV-infected persons | Q46639165 | ||
| Lung cancer mortality in relation to age, duration of smoking, and daily cigarette consumption: results from Cancer Prevention Study II. | Q47373574 | ||
| Durable remissions with autologous stem cell transplantation for high-risk HIV-associated lymphomas | Q47629271 | ||
| Screening colonoscopy for the detection of neoplastic lesions in asymptomatic HIV-infected subjects. | Q50599632 | ||
| Sustained remission of a primary nodal Merkel cell carcinoma in an HIV-positive patient. | Q53257942 | ||
| High-dose therapy and autologous peripheral blood stem cell transplantation as salvage treatment for AIDS-related lymphoma: long-term results of the Italian Cooperative Group on AIDS and Tumors (GICAT) study with analysis of prognostic factors. | Q53394007 | ||
| Case records of the Massachusetts General Hospital. Case 19-2008. A 63-year-old HIV-positive man with cutaneous Merkel-cell carcinoma. | Q53409079 | ||
| Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. | Q53608173 | ||
| Merkel cell carcinoma and HIV infection. | Q55035696 | ||
| MC polyomavirus is frequently present in Merkel cell carcinoma of European patients. | Q55050206 | ||
| Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study | Q56837790 | ||
| Differential Impact of Combination Antiretroviral Therapy in Preventing Kaposi's Sarcoma With and Without Visceral Involvement | Q56837833 | ||
| Cost-effectiveness of screening for anal precancers in HIV-positive men | Q58758401 | ||
| Trends in AIDS-Defining and Non--AIDS-Defining Malignancies among HIV-Infected Patients: 1989-2002 | Q58975060 | ||
| Treatment of HIV-associated invasive anal cancer with combined chemoradiation | Q59621990 | ||
| Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003 | Q64126680 | ||
| Rates of non-AIDS-defining cancers in people with HIV infection before and after AIDS diagnosis | Q74066963 | ||
| Lung cancer in HIV-infected patients in the era of highly active antiretroviral therapy | Q80100527 | ||
| Malignant progression of anal intra-epithelial neoplasia | Q80133201 | ||
| Increased metastasis and mortality from cutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemia | Q81535174 | ||
| Clinical presentation and outcome of colorectal cancer in HIV-positive patients: a clinical case-control study | Q84060548 | ||
| Risk of melanoma in people with HIV/AIDS in the pre- and post-HAART eras: a systematic review and meta-analysis of cohort studies. | Q35150769 | ||
| Efficacy of a bivalent HPV 16/18 vaccine against anal HPV 16/18 infection among young women: a nested analysis within the Costa Rica Vaccine Trial | Q35212868 | ||
| Merkel cell carcinoma associated with HIV: review of 14 patients. | Q35315354 | ||
| HIV-related lung cancer -- a growing concern? | Q35575070 | ||
| Hepatocellular carcinoma in HIV-infected patients: check early, treat hard | Q35584805 | ||
| HIV infection, immunodeficiency, viral replication, and the risk of cancer | Q35612742 | ||
| Lung cancer in HIV Infection. | Q35667193 | ||
| Systemic immune suppression predicts diminished Merkel cell carcinoma-specific survival independent of stage | Q36605019 | ||
| Risk of breast, ovary, and uterine corpus cancers among 85,268 women with AIDS. | Q36612286 | ||
| The risk of cancer in HIV-infected people in southeast England: a cohort study | Q36615747 | ||
| HIV as an independent risk factor for incident lung cancer | Q36632336 | ||
| Immunodeficiency-related Hodgkin lymphoma and its mimics | Q36799052 | ||
| Multicenter italian experience in liver transplantation for hepatocellular carcinoma in HIV-infected patients | Q36871711 | ||
| Including persons with HIV infection in cancer clinical trials | Q37098177 | ||
| Recurrence after treatment of cutaneous basal cell and squamous cell carcinomas in patients infected with human immunodeficiency virus | Q37104476 | ||
| AIDS-related malignancies: state of the art and therapeutic challenges | Q37203850 | ||
| Cutaneous malignancies among HIV-infected persons. | Q37387284 | ||
| Current questions in HIV-associated lung cancer | Q37529316 | ||
| Incidence and epidemiology of anal cancer in the multicenter AIDS cohort study | Q37710115 | ||
| Anal cancer: Focus on HIV-positive patients in the HAART-era | Q37853583 | ||
| Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis | Q37996691 | ||
| Assessing the impact of HAART on the incidence of defining and non-defining AIDS cancers among patients with HIV/AIDS: a systematic review. | Q38258003 | ||
| Incidence of HIV-related anal cancer remains increased despite long-term combined antiretroviral treatment: results from the french hospital database on HIV. | Q38429706 | ||
| Incidence of AIDS-defining cancers and virus-related and non-virus-related non-AIDS-defining cancers among HIV-infected patients compared with the general population in a large health district of Northern Italy, 1999-2009. | Q38929040 | ||
| Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection | Q39526550 | ||
| Response to highly active antiretroviral therapy strongly predicts outcome in patients with AIDS-related lymphoma | Q40579145 | ||
| Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration | Q42205361 | ||
| Prostate cancer incidence and prostate-specific antigen testing among HIV-positive and HIV-negative men. | Q42215621 | ||
| Cutaneous squamous cell carcinoma in human immunodeficiency virus-infected patients. A study of epidemiologic risk factors, human papillomavirus, and p53 expression | Q42438634 | ||
| Nonmelanoma skin cancers and infection with the human immunodeficiency virus | Q42460400 | ||
| Merkel cell polyomavirus and Merkel cell carcinoma, France | Q43227669 | ||
| Short- and long-term effects of highly active antiretroviral therapy on Kaposi sarcoma-associated herpesvirus immune responses and viraemia | Q43467153 | ||
| European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults. | Q43747979 | ||
| Stanford V regimen and concomitant HAART in 59 patients with Hodgkin disease and HIV infection. | Q44117626 | ||
| HIV-positive patients with liver metastases from colorectal cancer deserve the same therapeutic approach as the general population | Q44330914 | ||
| Liver transplantation for hepatocellular carcinoma: the impact of human immunodeficiency virus infection | Q44369203 | ||
| BEACOPP therapeutic regimen for patients with Hodgkin’s disease and HIV infection | Q44592612 | ||
| Vital signs: current cigarette smoking among adults aged >or=18 years --- United States, 2009. | Q44600343 | ||
| Effect of HIV on survival in patients with non-small-cell lung cancer in the era of highly active antiretroviral therapy: a population-based study | Q45063752 | ||
| Human immunodeficiency virus infection and non-small cell lung cancer: survival and toxicity of antineoplastic chemotherapy in a cohort study | Q45181648 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | virology | Q7215 |
| P304 | page(s) | 209-18 | |
| P577 | publication date | 2015-08-12 | |
| P1433 | published in | World journal of virology | Q27725044 |
| P1476 | title | Non-AIDS definings malignancies among human immunodeficiency virus-positive subjects: Epidemiology and outcome after two decades of HAART era | |
| P478 | volume | 4 |
| Q38907381 | Clinical and computed tomography findings in Chinese lung cancer patients with HIV infection: A multi-center study |
| Q38963668 | Does persistent HIV replication explain continued lymphoma incidence in the era of effective antiretroviral therapy? |
| Q60049153 | Global and regional trends of people living with HIV aged 50 and over: Estimates and projections for 2000-2020 |
| Q59354213 | HIV positivity may not have a negative impact on survival in Epstein-Barr virus-positive Hodgkin lymphoma: A Japanese nationwide retrospective survey |
| Q64280722 | Immunodeficiencies that predispose to pathologies by human oncogenic γ-herpesviruses |
| Q49725940 | Incidence of hepatocellular carcinoma in patients with chronic liver disease due to hepatitis B or C and coinfected with the human immunodeficiency virus: A retrospective cohort study |
| Q51777203 | Mortality and causes of death in people diagnosed with HIV in the era of highly active antiretroviral therapy compared with the general population: an analysis of a national observational cohort. |
| Q58109779 | Non-AIDS defining cancer (NADC) among HIV-infected patients at an oncology tertiary-care center in Mexico |
| Q38819315 | Non-infectious Pulmonary Diseases and HIV. |
| Q39106214 | Non-infectious pulmonary disorders in HIV. |
| Q37078107 | Risk of skin cancer in patients with diabetes mellitus: A nationwide retrospective cohort study in Taiwan |
| Q92137525 | Sleeping Beauty Mouse Models of Cancer: Microenvironmental Influences on Cancer Genetics |
Search more.